sábado, agosto 03, 2013

IATP: Biotech industry moves toward “transparency” while pulling the curtain over trade agreements


Posted August 1, 2013 by Dale Wiehoff   

Used under creative commons license from biocat.
A meeting of the Council for Biotechnology Information (BIO) in Europe in March 2013.
Earlier this week, Andrew Pollack reported in the New York Times that biotech companies like Monsanto, Dupont and Dow Chemical announced through an industry association that they would be more transparent with the public about the chemicals and genetically modified seeds they sell. According to Cathleen Enright, executive vice president at the Council for Biotechnology Information (BIO), “We have not done a very good job communicating about GMOs. We want to get into the conversation.”
To move that conversation along, they’ve opened a new web site, GMOAnswers.com. Any move toward greater transparency from companies who have spent decades suing farmers, spending millions to prevent the labeling of food containing GMOs, hiring private security firms to break into their critics offices and steal information—not to mention generally bullying anybody who questions the safety and value of their products—should be good news. But like with most news from chemical and seed companies, it is another reason to worry that the public will be misled and the issues will be futher obfuscated.

Etiquetas: ,

0 Comentarios:

Publicar un comentario

Suscribirse a Comentarios de la entrada [Atom]

<< Página Principal